Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2026-03-16 M&A Activity
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
INSIDE INFORMATION POTENTIAL DISPOSAL OF TIANMAI BIOTECHNOLOGY
M&A Activity Classification · 95% confidence The document is an announcement regarding a 'Potential Disposal' of equity interests in Tianmai Biotechnology by a subsidiary of China Resources Pharmaceutical Group Limited. It is filed under the 'Inside Information' provisions of the Hong Kong Listing Rules. Since it concerns a potential merger or acquisition-related transaction (disposal of assets), it falls under the M&A Activity category.
2026-03-16 English
DATE OF BOARD MEETING
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1544 characters) from China Resources Pharmaceutical Group Limited regarding the scheduling of a board meeting to approve upcoming annual results and dividend recommendations. It does not contain the actual financial results or the report itself, but rather serves as a notification of the publication date. Therefore, it falls under the 'Report Publication Announcement' category.
2026-03-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Share Issue/Capital Change Classification · 100% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and public float. Since it details changes in share capital and securities, it falls under the category of 'Share Issue/Capital Change'.
2026-03-02 English
INSIDE INFORMATION INVESTMENT IN AND CONSTRUCTION OF THE HEALTH CONSUMER PRODUCTS INDUSTRIAL PARK
Capital/Financing Update Classification · 95% confidence The document is an official announcement from China Resources Pharmaceutical Group Limited regarding a significant capital investment project (the construction of a health consumer products industrial park). It is filed under the Hong Kong Stock Exchange's 'Inside Information' provisions. Since it details a major capital expenditure and strategic investment project rather than a financial report, dividend, or management change, it falls under the 'Capital/Financing Update' category.
2026-02-10 English
INSIDE INFORMATION POTENTIAL DISPOSAL OF TIANMAI BIOTECHNOLOGY
M&A Activity Classification · 95% confidence The document is an announcement regarding a 'Potential Disposal' of equity interests in a subsidiary (Tianmai Biotechnology) by China Resources Pharmaceutical Group Limited. It is filed under the Hong Kong Stock Exchange regulatory framework as an 'Inside Information' announcement. Since it concerns a potential merger or acquisition-related transaction (disposal of assets), it falls under the M&A Activity category.
2026-02-09 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 100% confidence The document is the 'Articles of Association' for China Resources Pharmaceutical Group Limited. Articles of Association are foundational corporate governance documents that define the internal rules, board structure, and shareholder rights. According to the provided filing definitions, 'Governance Information' (CGR) is the category for reports detailing a company's internal rules, board structure, and governance practices. This document fits this definition perfectly.
2026-02-06 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.